These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8870154)

  • 1. The population risk as an explanatory variable in research synthesis of clinical trials.
    McIntosh MW
    Stat Med; 1996 Aug; 15(16):1713-28. PubMed ID: 8870154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
    Liu C; Shen W; Xie J
    Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
    Liu C; Xie J; Zhang Y
    Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML; Chinchilli VM
    Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis testing in an errors-in-variables model with heteroscedastic measurement errors.
    de Castro M; Galea M; Bolfarine H
    Stat Med; 2008 Nov; 27(25):5217-34. PubMed ID: 18561290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data.
    Stijnen T; Hamza TH; Ozdemir P
    Stat Med; 2010 Dec; 29(29):3046-67. PubMed ID: 20827667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of baseline covariates in crossover studies.
    Kenward MG; Roger JH
    Biostatistics; 2010 Jan; 11(1):1-17. PubMed ID: 19915170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M; Chen X
    Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
    Rozenberg P
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale.
    Thompson SG; Warn DE; Turner RM
    Stat Med; 2004 Feb; 23(3):389-410. PubMed ID: 14748035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating surrogate markers of clinical outcome when measured with error.
    Dafni UG; Tsiatis AA
    Biometrics; 1998 Dec; 54(4):1445-62. PubMed ID: 9883544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm labour. The present and future of tocolysis.
    Giles W; Bisits A
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian adjustment for covariate measurement errors: a flexible parametric approach.
    Hossain S; Gustafson P
    Stat Med; 2009 May; 28(11):1580-600. PubMed ID: 19226564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous toxicity monitoring in phase II trials in oncology.
    Ivanova A; Qaqish BF; Schell MJ
    Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality of randomised trials of tocolysis.
    Thornton JG
    BJOG; 2006 Dec; 113 Suppl 3():93-5. PubMed ID: 17206973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.